AZN logo

AstraZeneca (AZN) Current Assets

Annual Current Assets

$25.05 B
+$2.46 B+10.89%

31 December 2023

AZN Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Assets

$24.16 B
-$1.24 B-4.88%

30 September 2024

AZN Quarterly Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

AZN Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+10.9%+7.3%
3 y3 years+28.2%-9.5%
5 y5 years+60.7%+78.7%

AZN Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-4.5%+28.2%-9.5%+19.4%
5 y5 years-4.5%+61.0%-11.4%+88.4%
alltimeall time-4.5%+606.3%-11.4%+431.1%

AstraZeneca Current Assets History

DateAnnualQuarterly
Sept 2024
-
$24.16 B(-4.9%)
June 2024
-
$25.39 B(-0.8%)
Mar 2024
-
$25.59 B(+2.2%)
Dec 2023
$76.06 B(+2.9%)
$25.05 B(+11.3%)
Sept 2023
-
$22.50 B(-1.5%)
June 2023
-
$22.84 B(+2.6%)
Mar 2023
-
$22.27 B(-1.4%)
Dec 2022
$73.89 B(-6.6%)
$22.59 B(+11.7%)
Sept 2022
-
$20.22 B(-3.3%)
June 2022
-
$20.92 B(-7.6%)
Mar 2022
-
$22.65 B(-13.7%)
Dec 2021
$79.12 B(+67.7%)
$26.24 B(-1.7%)
Sept 2021
-
$26.69 B(-2.1%)
June 2021
-
$27.27 B(+45.6%)
Mar 2021
-
$18.73 B(-4.1%)
Dec 2020
$47.19 B(+3.0%)
$19.54 B(+7.6%)
Sept 2020
-
$18.17 B(+21.7%)
June 2020
-
$14.93 B(+16.4%)
Mar 2020
-
$12.82 B(-17.6%)
Dec 2019
$45.81 B(+1.7%)
$15.56 B(+15.1%)
Sept 2019
-
$13.52 B(-11.2%)
June 2019
-
$15.22 B(+11.5%)
Mar 2019
-
$13.65 B(-12.5%)
Dec 2018
$45.06 B(-10.2%)
$15.59 B(+18.9%)
Sept 2018
-
$13.11 B(+5.3%)
June 2018
-
$12.45 B(-5.6%)
Mar 2018
-
$13.18 B(+0.2%)
Dec 2017
$50.20 B(+1.9%)
$13.15 B(-3.5%)
Sept 2017
-
$13.63 B(-4.6%)
June 2017
-
$14.30 B(+22.9%)
Mar 2017
-
$11.64 B(-12.3%)
Dec 2016
$49.26 B(+11.8%)
$13.26 B(+3.1%)
Sept 2016
-
$12.87 B(-3.4%)
June 2016
-
$13.32 B(+4.3%)
Mar 2016
-
$12.77 B(-20.2%)
Dec 2015
$44.05 B(+5.1%)
$16.01 B(+21.3%)
Sept 2015
-
$13.20 B(-4.4%)
June 2015
-
$13.81 B(+8.8%)
Mar 2015
-
$12.69 B(-24.0%)
Dec 2014
$41.90 B(+17.8%)
$16.70 B(+10.8%)
Sept 2014
-
$15.07 B(-7.0%)
June 2014
-
$16.20 B(-2.0%)
Mar 2014
-
$16.54 B(-18.7%)
Dec 2013
$35.56 B(+3.1%)
$20.34 B(+8.2%)
Sept 2013
-
$18.79 B(-3.1%)
June 2013
-
$19.39 B(+5.7%)
Mar 2013
-
$18.34 B(-3.7%)
Dec 2012
$34.49 B(+17.6%)
$19.05 B(+5.7%)
Sept 2012
-
$18.03 B(-8.8%)
June 2012
-
$19.78 B(-8.3%)
Mar 2012
-
$21.56 B(-8.3%)
Dec 2011
$29.32 B(-5.4%)
$23.51 B(+4.6%)
Sept 2011
-
$22.47 B(-1.0%)
June 2011
-
$22.69 B(-3.3%)
Mar 2011
-
$23.47 B(-6.6%)
Dec 2010
$31.00 B
$25.13 B(+2.3%)
DateAnnualQuarterly
Sept 2010
-
$24.57 B(+5.1%)
June 2010
-
$23.38 B(+4.6%)
Mar 2010
-
$22.35 B(-5.9%)
Dec 2009
$31.16 B(+0.3%)
$23.76 B(+15.7%)
Sept 2009
-
$20.54 B(+7.4%)
June 2009
-
$19.13 B(+20.7%)
Mar 2009
-
$15.85 B(-0.1%)
Dec 2008
$31.08 B(+0.7%)
$15.87 B(+1.9%)
Sept 2008
-
$15.57 B(-5.5%)
June 2008
-
$16.48 B(+14.0%)
Mar 2008
-
$14.45 B(-15.4%)
Dec 2007
$30.88 B(+137.6%)
$17.08 B(+16.3%)
Sept 2007
-
$14.69 B(-8.6%)
June 2007
-
$16.08 B(-1.3%)
Mar 2007
-
$16.29 B(-3.8%)
Dec 2006
$13.00 B(+17.4%)
$16.94 B(+17.3%)
Sept 2006
-
$14.43 B(-4.1%)
June 2006
-
$15.05 B(-11.1%)
Mar 2006
-
$16.94 B(+23.0%)
Dec 2005
$11.07 B(-12.3%)
$13.77 B(+5.2%)
Sept 2005
-
$13.10 B(-2.6%)
June 2005
-
$13.44 B(-2.4%)
Mar 2005
-
$13.77 B(+5.7%)
Dec 2004
$12.63 B(+18.7%)
$13.03 B(+6.3%)
Sept 2004
-
$12.25 B(+2.9%)
June 2004
-
$11.91 B(-10.2%)
Mar 2004
-
$13.26 B(+2.5%)
Dec 2003
$10.64 B(+12.6%)
$12.93 B(-0.5%)
Sept 2003
-
$13.00 B(+6.0%)
June 2003
-
$12.27 B(-5.3%)
Mar 2003
-
$12.95 B(+6.8%)
Dec 2002
$9.45 B(+16.2%)
$12.13 B(+5.2%)
Sept 2002
-
$11.53 B(+1.0%)
June 2002
-
$11.42 B(-3.0%)
Mar 2002
-
$11.77 B(+13.6%)
Dec 2001
$8.13 B(+2.6%)
$10.36 B(-7.1%)
Sept 2001
-
$11.16 B(+3.6%)
June 2001
-
$10.77 B(-5.9%)
Mar 2001
-
$11.45 B(+8.8%)
Dec 2000
$7.93 B(-20.0%)
$10.52 B(-5.6%)
Sept 2000
-
$11.15 B(+8.7%)
June 2000
-
$10.25 B(-2.4%)
Mar 2000
-
$10.50 B(+5.9%)
Dec 1999
$9.90 B(+9.1%)
$9.91 B(-5.2%)
Sept 1999
-
$10.46 B(+7.2%)
June 1999
-
$9.76 B(+3.8%)
Dec 1998
$9.07 B(+154.8%)
$9.40 B(+99.6%)
June 1998
-
$4.71 B(-0.2%)
Dec 1997
$3.56 B(+5.8%)
$4.72 B(-9.2%)
Dec 1996
$3.37 B(+12.0%)
$5.20 B(+6.8%)
Dec 1995
$3.01 B(+8.5%)
$4.86 B(+0.5%)
June 1995
-
$4.84 B(+6.5%)
Dec 1994
$2.77 B(+9.5%)
$4.55 B(-7.1%)
Dec 1993
$2.53 B(+4.8%)
$4.89 B
Dec 1992
$2.41 B(-6.8%)
-
Dec 1991
$2.59 B(+1.5%)
-
Dec 1990
$2.55 B
-

FAQ

  • What is AstraZeneca annual total current assets?
  • What is the all time high annual current assets for AstraZeneca?
  • What is AstraZeneca annual current assets year-on-year change?
  • What is AstraZeneca quarterly total current assets?
  • What is the all time high quarterly current assets for AstraZeneca?
  • What is AstraZeneca quarterly current assets year-on-year change?

What is AstraZeneca annual total current assets?

The current annual current assets of AZN is $25.05 B

What is the all time high annual current assets for AstraZeneca?

AstraZeneca all-time high annual total current assets is $26.24 B

What is AstraZeneca annual current assets year-on-year change?

Over the past year, AZN annual total current assets has changed by +$2.46 B (+10.89%)

What is AstraZeneca quarterly total current assets?

The current quarterly current assets of AZN is $24.16 B

What is the all time high quarterly current assets for AstraZeneca?

AstraZeneca all-time high quarterly total current assets is $27.27 B

What is AstraZeneca quarterly current assets year-on-year change?

Over the past year, AZN quarterly total current assets has changed by +$1.65 B (+7.35%)